Pfizer's Strong Quarter Bolsters CEO's Comeback Efforts

Pfizer has countered activist investor Starboard Value by reporting positive quarterly earnings. The company has revised its annual revenue forecast upward to a range between $61 billion and $64 billion, previously estimated at $59.5 billion to $62.5 billion. Additionally, Pfizer increased its guidance on adjusted annual earnings per share to between $2.75 and $2.95, compared to the earlier range of $2.45 to $2.65 per share.